Showing results (131-140 of 339) with videos related to

Sort By:
Pageof 34
Antimicrobial Agents and Chemotherapy|July 22, 2015
Differential Effects of Penicillin Binding Protein Deletion on the Susceptibility of Enterococcus faecium to Cationic Peptide AntibioticsGeorge Sakoulas, Monika Kumaraswamy, Poochit Nonejuie, et al.
Antimicrobial Agents and Chemotherapy|September 11, 2025
Therapeutic approach to difficult-to-treat multidrug-resistant enterococcal infectionsAdrianna M Turner, Paul Kinsella, William R Miller, et al.
Plos One|September 7, 2012
Daptomycin resistance in enterococci is associated with distinct alterations of cell membrane phospholipid contentNagendra N Mishra, Arnold S Bayer, Truc T Tran, et al.
Antimicrobial Agents and Chemotherapy|July 24, 2019
Environment Shapes the Accessible Daptomycin Resistance Mechanisms in Enterococcus faeciumAmy G Prater, Heer H Mehta, Abigael J Kosgei, et al.
Applied and Environmental Microbiology|May 22, 2016
Exogenous Fatty Acids Protect Enterococcus faecalis from Daptomycin-Induced Membrane Stress Independently of the Response Regulator LiaRJohn R Harp, Holly E Saito, Allen K Bourdon, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 9, 2021
Emergence and Transmission of Daptomycin and Vancomycin-Resistant Enterococci Between Patients and Hospital RoomsLynn El Haddad, Blake M Hanson, Cesar A Arias, et al.
Antimicrobial Agents and Chemotherapy|May 11, 2022
Evolution of Enterococcus faecium in Response to a Combination of Daptomycin and Fosfomycin Reveals Distinct and Diverse Adaptive StrategiesAdeline Supandy, Heer H Mehta, Truc T Tran, et al.
Antimicrobial Agents and Chemotherapy|June 6, 2012
Correlation between mutations in liaFSR of Enterococcus faecium and MIC of daptomycin: revisiting daptomycin breakpointsJose M Munita, Diana Panesso, Lorena Diaz, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 11, 2022
Emergence of Clinical Clostridioides difficile Isolates With Decreased Susceptibility to VancomycinCharles Darkoh, Kadiatou Keita, Chioma Odo, et al.
Antimicrobial Agents and Chemotherapy|September 26, 2022
Meropenem plus Ceftaroline Is Active against Enterococcus faecalis in an In Vitro Pharmacodynamic Model Using Humanized Dosing SimulationsJaclyn A Cusumano, Kathryn E Daffinee, Emily C Piehl, et al.
Pageof 34